A platform for glycoengineering a polyvalent pneumococcal bioconjugate vaccine using E. coli as a host
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A platform for glycoengineering a polyvalent pneumococcal bioconjugate vaccine using E. coli as a host
Authors
Keywords
-
Journal
Nature Communications
Volume 10, Issue 1, Pages -
Publisher
Springer Nature
Online
2019-02-21
DOI
10.1038/s41467-019-08869-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Production and efficacy of a low-cost recombinant pneumococcal protein polysaccharide conjugate vaccine
- (2018) Jenny A. Herbert et al. VACCINE
- Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000–15
- (2018) Brian Wahl et al. Lancet Global Health
- Design and production of conjugate vaccines against S. Paratyphi A using an O-linked glycosylation system in vivo
- (2018) Peng Sun et al. npj Vaccines
- Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial
- (2017) Angela Huttner et al. LANCET INFECTIOUS DISEASES
- Pneumococcal serotype distribution: A snapshot of recent data in pediatric and adult populations around the world
- (2017) Yadong A. Cui et al. Human Vaccines & Immunotherapeutics
- Safety and Immunogenicity of a Candidate Bioconjugate Vaccine against Shigella flexneri 2a Administered to Healthy Adults: a Single-Blind, Randomized Phase I Study
- (2016) Mark S. Riddle et al. Clinical and Vaccine Immunology
- Biosynthesis of Conjugate Vaccines Using an O-Linked Glycosylation System
- (2016) Chao Pan et al. mBio
- Recombinant expression ofStreptococcus pneumoniaecapsular polysaccharides inEscherichia coli
- (2016) Emily J. Kay et al. Open Biology
- Glycoengineered Outer Membrane Vesicles: A Novel Platform for Bacterial Vaccines
- (2016) Nancy L. Price et al. Scientific Reports
- Pneumococcal Capsules and Their Types: Past, Present, and Future
- (2015) K. Aaron Geno et al. CLINICAL MICROBIOLOGY REVIEWS
- Acinetobacterstrains carry two functional oligosaccharyltransferases, one devoted exclusively to type IV pilin, and the other one dedicated toO-glycosylation of multiple proteins
- (2015) Christian M. Harding et al. MOLECULAR MICROBIOLOGY
- Five winters of pneumococcal serotype replacement in UK carriage following PCV introduction
- (2015) Rebecca A. Gladstone et al. VACCINE
- Increased efficiency of Campylobacter jejuni N-oligosaccharyltransferase PglB by structure-guided engineering
- (2015) J. Ihssen et al. Open Biology
- Predicting the impact of new pneumococcal conjugate vaccines: serotype composition is not enough
- (2014) William P Hausdorff et al. Expert Review of Vaccines
- Diversity Within theO-linked Protein Glycosylation Systems ofAcinetobacterSpecies
- (2014) Nichollas E. Scott et al. MOLECULAR & CELLULAR PROTEOMICS
- Differences in serious clinical outcomes of infection caused by specific pneumococcal serotypes among adults
- (2014) John D. Grabenstein et al. VACCINE
- Pour some sugar on it: the expanding world of bacterial proteinO-linked glycosylation
- (2013) Jeremy A. Iwashkiw et al. MOLECULAR MICROBIOLOGY
- Systematic Review of the Effect of Pneumococcal Conjugate Vaccine Dosing Schedules on Prevention of Pneumonia
- (2013) Jennifer D. Loo et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Development and Validation of a Novel Diagnostic Test for Human Brucellosis Using a Glyco-engineered Antigen Coupled to Magnetic Beads
- (2013) Andrés E. Ciocchini et al. PLoS Neglected Tropical Diseases
- Exploiting the Campylobacter jejuni protein glycosylation system for glycoengineering vaccines and diagnostic tools directed against brucellosis
- (2012) Jeremy A Iwashkiw et al. Microbial Cell Factories
- A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design
- (2011) Fikri Y Avci et al. NATURE MEDICINE
- Correlates of Protection Induced by Vaccination
- (2010) S. A. Plotkin Clinical and Vaccine Immunology
- Protein glycosylation in bacteria: sweeter than ever
- (2010) Harald Nothaft et al. NATURE REVIEWS MICROBIOLOGY
- Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine
- (2009) Tamara Pilishvili et al. JOURNAL OF INFECTIOUS DISEASES
- Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates
- (2009) Katherine L O'Brien et al. LANCET
- Broad spectrum O-linked protein glycosylation in the human pathogen Neisseria gonorrhoeae
- (2009) A. Vik et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Preparation of bacterial polysaccharide–protein conjugates: Analytical and manufacturing challenges
- (2009) Carl E. Frasch VACCINE
- Extreme Substrate Promiscuity of theNeisseriaOligosaccharyl Transferase Involved in ProteinO-Glycosylation
- (2008) Amirreza Faridmoayer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started